BridgeMD
New treatment option for Transitional Care
Official title Pharmacist-Led Transition of Care Program in the Emergency Department (Pharm TOC-ED): A Pilot Trial
ClinicalTrials.gov ID: NCT07310199
What this study is testing
- What it's testing
- When patients leave the emergency department, mistakes with their medications are common and can lead to complications or hospital readmissions. Pharmacists are trained to help prevent these problems, but pharmacist-led transition of care services are not routinely provided in emergency departments.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults (aged 18 years or more) discharged from the ED with at least one of the following:
- Polypharmacy: Five or more scheduled prescription medications for chronic illnesses (i.e., chronic maintenance medications, even if such medications...
- Discharged with a new prescription of high-risk medication, including:
- Drugs with the potential of withdrawal symptoms upon abrupt discontinuation such as antipsychotics, antiepileptics, antidepressants, and tapering...
- Insulin (initiation or intensification of therapy)
You likely can't join if
- The following patients will be excluded:
- Presenting with acute minor illnesses
- Lack of decision-making capacity (including documented moderate or severe dementia, altered mental status, unstable psychiatric illness, altered...
- Language barrier, i.e., inability to communicate in either English or Arabic as the intervention will be provided by English/Arabic speaking clinical...
- Expected length of stay in Qatar of \<30 days post discharge (including transit passengers)
- Substance use disorders (e.g., alcoholism, opioid dependency) or drug-seeking behavior, as reported in EHR
See the full eligibility criteria
- Adults (aged 18 years or more) discharged from the ED with at least one of the following:
- Polypharmacy: Five or more scheduled prescription medications for chronic illnesses (i.e., chronic maintenance medications, even if such medications were not refilled during the index ED visit)
- Discharged with a new prescription of high-risk medication, including:
- Drugs with the potential of withdrawal symptoms upon abrupt discontinuation such as antipsychotics, antiepileptics, antidepressants, and tapering glucocorticoids.
- Insulin (initiation or intensification of therapy)
- Oral hypoglycemic agents
- Visiting ED for an exacerbation of chronic illness (e.g., exacerbation of asthma, COPD, CHF, uncontrolled diabetes mellitus, hypertension urgency, uncontrolled epilepsy)
- The following patients will be excluded:
- Presenting with acute minor illnesses
- Lack of decision-making capacity (including documented moderate or severe dementia, altered mental status, unstable psychiatric illness, altered consciousness level, lack of orientation to person/place/time as reported...
- Language barrier, i.e., inability to communicate in either English or Arabic as the intervention will be provided by English/Arabic speaking clinical pharmacists
- Expected length of stay in Qatar of \<30 days post discharge (including transit passengers)
- Substance use disorders (e.g., alcoholism, opioid dependency) or drug-seeking behavior, as reported in EHR
- Prisoners who are serving an active sentence
- Patients presenting for non-medical, socially driven reasons (e.g., seeking shelter, support, or resources) with no identifiable acute medical condition, and known to the ED team as recurrent visitors.
- Discharge to a location other than home (e.g., patients transferred to another hospital, long-term or skilled nursing facility)
- Study pharmacists unavailable to deliver the intervention if the patients were assigned by chance to the intervention arm
- Pregnant women
- Patients seen for trauma or planned surgery
- Terminally ill patients
- Patients discharged from ED with watchful waiting (e.g., expected to be readmitted for an intervention such as surgical intervention if conservative management failed)
- Patients who are admitted to the hospital after enrollment (i.e., following consent but prior to ED discharge)
The study team makes the final eligibility decision.
Where it's taking place
- Al Wakrah, Qatar
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Al Wakrah, Qatar. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.